9 insiders reported 14 Form 4 transactions for Immix Biopharma, Inc. (IMMX) over the past 18 months (most recent 2026-05-29). Recent activity: BUCHAN JANE (Director) Buy 6,250 shares, CHANG NANCY T (Director) Buy 6,250 shares, Adams Helen C. (Director) Buy 6,250 shares, Marquet Magda (Director) Buy 6,250 shares, Ng Carey (Director) Buy 6,250 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-29 | BUCHAN JANE | Director | Buy | 6,250 | $0 |
| 2026-05-29 | CHANG NANCY T | Director | Buy | 6,250 | $0 |
| 2026-05-29 | Adams Helen C. | Director | Buy | 6,250 | $0 |
| 2026-05-29 | Marquet Magda | Director | Buy | 6,250 | $0 |
| 2026-05-29 | Ng Carey | Director | Buy | 6,250 | $0 |
| 2026-05-29 | Hsu Jason | Director | Buy | 6,250 | $0 |
| 2026-05-29 | Chudnovsky Yekaterina | Director | Buy | 6,250 | $0 |
| 2025-12-10 | Morris Gabriel S | CFO | Buy | 156,000 | $124,800 |
| 2025-12-10 | Morris Gabriel S | CFO | Buy | 770 | $5,067 |
| 2025-12-10 | Rachman Ilya M | CEO and Chairman | Buy | 746 | $4,976 |
| 2025-09-17 | Morris Gabriel S | CFO | Buy | 2,600 | $5,122 |
| 2025-09-17 | Rachman Ilya M | CEO and Chairman | Buy | 2,500 | $5,050 |
| 2025-06-20 | Rachman Ilya M | CEO and Chairman | Buy | 2,178 | $5,009 |
| 2025-06-20 | Morris Gabriel S | CFO | Buy | 2,225 | $5,073 |
Source: SEC Form 4 filings · as of 2026-05-29